HK Red Cross Blood Transfusion Service, Hong Kong Report issue

Foundation

Organization Overview

First Clinical Trial
2010
NCT01617317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2